Tech Company Financing Transactions

Precirix Funding Round

BioMedPartners, GIMV and Healthcap Venture Capital participated in a funding round for Precirix. The round was announced on 3/24/2022.

Transaction Overview

Company Name
Precirix
Announced On
3/24/2022
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors

BioMedPartners (Lead Investor)

GIMV (Lead Investor) (Karl Naegler)

Healthcap Venture Capital (Lead Investor) (Mårten Steen)

Novo Ventures (Lead Investor) (Morten Døssing)

Pontifax Fund (Lead Investor) (Ohad Hammer)

V-Bio Ventures (Lead Investor) (Christina Takke)

Proceeds Purpose
The proceeds will enable Camel-IDS to run a phase Ib/II trial with its lead program CAM-H2 targeting HER2-positive brain metastatic breast cancer, while further progressing and broadening its preclinical pipeline.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Burgemeester Etienne Demunterlaan 1
Brussels, B-1090
Belgium
Phone
+32 2 479 93 60
Website
www.precirix.com
Email Address
[email protected]
Overview
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.
Profile
Precirix LinkedIn Company Profile
Social Media
Precirix Company Twitter Account
Company News
Precirix News
Facebook
Precirix on Facebook
YouTube
Precirix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ruth Devenyns
  Ruth Devenyns LinkedIn Profile  Ruth Devenyns Twitter Account  Ruth Devenyns News  Ruth Devenyns on Facebook
Chief Scientific Officer
Tony Lahoutte
  Tony Lahoutte LinkedIn Profile  Tony Lahoutte Twitter Account  Tony Lahoutte News  Tony Lahoutte on Facebook
Chief Technical Officer
Niva Almaula
  Niva Almaula LinkedIn Profile  Niva Almaula Twitter Account  Niva Almaula News  Niva Almaula on Facebook
VP - Bus. Development
Niva Almaula
  Niva Almaula LinkedIn Profile  Niva Almaula Twitter Account  Niva Almaula News  Niva Almaula on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/24/2022: SucceedSmart venture capital transaction
Next: 3/24/2022: Nucleai venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.